5564471539 · Annan naturvetenskaplig och teknisk forskning och utveckling · BORLÄNGE
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
In 2025, the operating margin rose to 11.5 %, from 5.3 % the period before. ASPIRA MEDICAL Aktiebolag has been profitable for three fiscal periods in a row, 2023–2025. ASPIRA MEDICAL Aktiebolag generated roughly 3.9 MSEK in net sales per employee in 2025.
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
35.4 MSEK
▲ +13%Net result
3.3 MSEK
▲ +131%Employees
9
▼ −10%Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
arkivnord